Effective and safe IV iron and anemia management during home hemodialysis: a dialysis facility's experience.
Studies have shown that IV iron therapy, in conjunction with EPO, is essential in managing anemia in patients on hemodialysis. In addition, data have shown that IV iron therapy can be safely administered during hemodialysis, whether performed at home or in the center. Nurses should be aware of how to administer this therapy and be knowledgable of possible allergic-type reactions that have been associated with its clinical use.
Utley
Monica
M
Home Training Program Director of Virginia, Renal Advantage, Inc., Virginia Commonwealth University Health System, Richmond, VA, USA.
D000328:Adult; D000368:Aged; D018798:Anemia, Iron-Deficiency / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000628:therapy*; D002985:Clinical Protocols; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D005260:Female; D005290:Ferric Compounds / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D006437:Hemodialysis, Home / Q000009:adverse effects / Q000379:methods / Q000451:nursing; D018718:Home Infusion Therapy / Q000379:methods / Q000451:nursing; D006801:Humans; D007262:Infusions, Intravenous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012449:Safety; D012646:Self Administration / Q000379:methods; D014168:Transferrin / Q000378:metabolism; D016896:Treatment Outcome
D005290:Ferric Compounds; D014168:Transferrin; D005293:Ferritins; C035552:ferric gluconate